AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
SERTRALINE HYDROCHLORIDE in Zimbabwe
1 product registered with MCAZ β 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CP-SERTRALINE 50 TABLET, COATED; ORAL | 2025/13.2.1/6891 | COSPHARM PHARMACEUTICALS | active | 6 Mar 2030 |
SERTRALINE HYDROCHLORIDE β MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing SERTRALINE HYDROCHLORIDE, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track SERTRALINE HYDROCHLORIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.